Anzeige
Mehr »
Donnerstag, 19.02.2026 - Börsentäglich über 12.000 News
Die größte Bewertungslücke im globalen Mental-Health-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16:45Medtronic renal denervation has a reimbursement win in Japan
16:15GE HealthCare wins FDA nod for next-gen Signa MRI tech
15:15Gore completes Conformal Medical acquisition
14:15Sequel, Senseonics announce full launch of Eversense 365 CGM, twiist pump pairing
13:15St. Jude Medical founder Manny Villafaña looks to take Medical 21 venture public
MiInVera Medical wins European approval for vein infusion device
MiProSomnus raises $38M for CPAP alternative
MiFDA expands age indication for Staar Surgical EVO ICL
MiInsulet stock rises before hours on Street-beating Q4, 31% sales growth
MiAtriCure posts Q4 beats on 13% growth, analysts label it 'undervalued' despite rising competition
DiMedtronic completes first U.S. cases with Hugo
DiMedtronic gets FDA nod for Infuse bone graft in TLIF procedures
DiZimmer Biomet, Paragon 28 announce commercial launch of curved TTC nail system
DiNeuromod Devices reports positive Lenire tinnitus device data
DiGE HealthCare, BARDA expand collab with $35M AI-powered ultrasound expansion
DiPortal Diabetes earns FDA breakthrough nod for implantable insulin pump
DiMedtronic U.S. cardiac ablations business more than doubled in Q3
DiDanaher reportedy nears $10B deal to buy Masimo
DiEuropean Commission ends Edwards antitrust probe after company withdraws anti-copycat policy
MoVB Spine to acquire Augmedics' augmented reality navigation tech
FrProfusa, Mayo Clinic collab on oxygen monitoring tech
FrMedtronic wins FDA nod for surgical robot for spine procedures
FrPhilips introduces flexible pediatric MRI coil
FrSiemens Healthineers, Mayo Clinic collab to treat neurodegenerative disease
FrStructural heart treatment developer BioVentrix files for IPO